Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new reminyl clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on reminyl
- A Randomized, Double-Blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer Disease - A Double-Blind, Placebo-Controlled, 2-Year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease.
Status: Not yet recruiting, Condition Summary: Dementia, Alzheimer Type; Alzheimer Disease - Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
Status: Terminated, Condition Summary: Alzheimer's Disease - A Single Dose, Cross-Over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers
Status: Completed, Condition Summary: Pharmacokinetics - Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer's Disease - An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
Status: Completed, Condition Summary: Chronic Schizophrenia - An Observational Study of the Vital Status Data of Patients (Living or Deceased) Who Participated in Three Previous Studies of Galantamine for the Treatment of Mild Cognitive Impairment
Status: Completed, Condition Summary: Dementia - A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
Status: Completed, Condition Summary: Nervous System Diseases; Brain Diseases; Cognition Disorder; Mental Disorders - A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.
Status: Completed, Condition Summary: Schizophrenia - Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)
Status: Recruiting, Condition Summary: Alzheimer's Disease - The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia
Status: Recruiting, Condition Summary: Schizophrenia - The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)
Status: Active, not recruiting, Condition Summary: Dementia; Alzheimer's Disease - Galantamine Effects on Cognitive Function in Abstinent Cocaine Users
Status: Recruiting, Condition Summary: Abstinent Cocaine Users - Galantamine for Cognitive Deficits in Schizophrenia
Status: Completed, Condition Summary: Schizophrenia - The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
Status: Active, not recruiting, Condition Summary: Major Depression; Bipolar Depression; Schizoaffective Disorder, Depressed Type - The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
Status: Completed, Condition Summary: Alzheimer Disease - A Study of the Safety and Effectiveness of Galantamine Hydrobromide (REMINYL®) in Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Brain Diseases; Alzheimer Disease; Mental Disorders; Nervous System Diseases; Dementia - A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Mental Disorders; Alzheimer Disease; Brain Diseases; Dementia - A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Status: Completed, Condition Summary: Pick Complex; Frontotemporal Dementia - Long-Term Safety and Efficacy of Galantamine in Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer Disease - Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer's Disease; Dementia - Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
Status: Recruiting, Condition Summary: Alzheimer's Disease - Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
Status: Completed, Condition Summary: Schizophrenia; Schizoaffective Disorder - A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer Disease - A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
Status: Completed, Condition Summary: Alzheimer Disease; Dementia - A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
Status: Completed, Condition Summary: Alzheimer Disease; Dementia - A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
Status: Completed, Condition Summary: Alzheimer Disease; Vascular Dementia - A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Dementia; Alzheimer Disease - A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Dementia; Alzheimer Disease - A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Status: Completed, Condition Summary: Alzheimer Disease; Dementia